Such efforts would take partnerships between industry and academic institutions — which are already essential to medical innovation — to a new level.
Before COVID-19 struck, major health systems had started selling the "mining rights" to troves of their health data and stored materials — including details about patients' DNA found in samples of their blood or tissue.
|